Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors Using Fludarabine, Busulfan, TBI, and Thymoglobulin
NCT00679536Phase 2Unknown
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- May 2008
- Primary completion
- May 2015
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan, fludarabine, antithymocyte globulin in leukemia, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Status: unknown.
02
Drugs
busulfanfludarabineantithymocyte globulin
03
Conditions
leukemia
Beyond the preview
Go deeper on NCT00679536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679536.